Floatz logo

Immunoglobulin G4 [236-proline], anti-(human interleukin 1?) (human monoclonal GenSci048 ?4-chain), disulfide with human monoclonal GenSci048 ?-chain, dimer

Resistant Cancer

Tongji Hospitalmonoclonal_antibodyN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

180 Active assets in the Resistant Cancer cohort.

Asset / SponsorPhaseRating
Catequentinib
Nanfang Hospital, Southern Medical University
Phase 3BB
Irinotecan
M.D. Anderson Cancer Center
Phase 2BB
Durvalumab
OHSU Knight Cancer Institute
Phase 2BB
Cediranib
National Cancer Institute (NCI)
Phase 2BB
Sugemalimab
Second Affiliated Hospital of Soochow University
Phase 2BB

View all 50 →

Same molecule, other indications

Immunoglobulin G4 [236-proline], anti-(human interleukin 1?) (human monoclonal GenSci048 ?4-chain), disulfide with human monoclonal GenSci048 ?-chain, dimer is also rated in:

hepatocellular carcinomaDormant
D
Indicative ·
30 / 100
View asset →
UnresectableDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →